Invesaro

Stocks Industrials KEQU

NASDAQ · Industrials

Kewaunee Scientific Corp (KEQU)

Kewaunee Scientific Corp brought in $277.2M of revenue over the twelve months to July 31, 2026, up 5.3% from a year earlier. Net income was $8.2M, a net margin of 3.0%. Operating cash flow minus capital spending left $14.7M of free cash flow in fiscal 2026. At July 31, 2026 it held $8.2M in cash against $18.8M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 11, 2026.

Free, no password. An email when KEQU files with the SEC.

Price
$33.72
-1.17% on the day · November 9, 2026
52-week range $32.00 to $43.36
Market cap
$96.8M
Revenue (last 12 months)
$277.2M
+5.3% year on year
Net margin
3.0%
P/E
10.5
on FY2026 diluted EPS

Key facts about Kewaunee Scientific Corp

Net worth
Kewaunee Scientific Corp has a market value (market cap) of $96.8M at the latest share price, and shareholders' equity of $75M on its balance sheet at July 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2026 revenue was $282M (+17.3% year on year), with net income of $9.6M. Over the 12 months to July 31, 2026: revenue $277.2M, net income $8.2M.
Cash flow
In fiscal 2026 operations brought in $18.6M of cash; after $3.9M of capital spending, free cash flow was $14.7M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on September 11, 2026 and covers the period to July 31, 2026. Open on SEC EDGAR
Next earnings report
Kewaunee Scientific Corp's next report is expected around December 9, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Kewaunee Scientific Corp does

Kewaunee Scientific Corp is registered with the SEC under industry code SIC 3821 (Laboratory Apparatus & Furniture). Its shares trade on NASDAQ under the ticker KEQU.

Revenue and profit by year

Revenue
FY19: $146.6M $146.6M FY19FY20: $147.5M $147.5M FY20FY21: $147.5M $147.5M FY21FY22: $168.9M $168.9M FY22FY23: $219.5M $219.5M FY23FY24: $203.8M $203.8M FY24FY25: $240.5M $240.5M FY25FY26: $282M $282M FY26
Net income
FY19: $1.5M $1.5M FY19FY20: -$4.7M -$4.7M FY20FY21: -$3.7M -$3.7M FY21FY22: -$6.1M -$6.1M FY22FY23: $738K $738K FY23FY24: $18.8M $18.8M FY24FY25: $11.4M $11.4M FY25FY26: $9.6M $9.6M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$282M$16.7M$9.6M$3.22$14.7M
2025$240.5M$17.8M$11.4M$3.83$12.6M
2024$203.8M$18.3M$18.8M$6.38$15.2M
2023$219.5M$5.4M$738K$0.25-$7.9M
2022$168.9M-$2.6M-$6.1M-$2.20-$9.8M
2021$147.5M-$1.3M-$3.7M-$1.33-$1.5M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around December 9, 2026.

Estimated from its filing rhythm: 52 weeks after its report of December 10, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where KEQU ranks in Industrials

Revenue$282M
#365 of 603 in Industrials · Bottom 40%
Revenue growth+17.3%
#103 of 520 in Industrials · Top 20%
Net margin3.4%
#257 of 523 in Industrials · Top 49%
Free cash flow margin5.2%
#238 of 489 in Industrials · Top 49%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Industrials

Dividends

Fiscal yearPer sharePaid outOf profit
2021n/a$0n/a
2020$0.38$1Mn/a
2019$0.74$2M133%
2018$0.66$1.8M34%
2017$0.58$1.6M35%
2016$0.51$1.4Mn/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Kewaunee Scientific Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 11, 2026
    Quarterly report 10-Q · period to July 31, 2026Revenue fell 6.7% to $66.3M versus the same quarter last year; diluted EPS $0.58 versus $1.04.
  2. September 9, 2026
  3. August 27, 2026
  4. August 26, 2026
  5. August 25, 2026
  6. July 7, 2026
  7. July 7, 2026
  8. July 7, 2026
  9. June 29, 2026
  10. June 26, 2026
    Annual report 10-K · period to April 30, 2026Revenue rose 17% to $282M versus the prior year; diluted EPS $3.22 versus $3.83.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 2, 2026. Insider transactions on SEC

What is KEQU worth? A DCF from its reported cash flow

Insider trades

What the people running Kewaunee Scientific Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
June 30, 2026 Phillips Elizabeth DSVP, People & Culture Exercised options 6,656 - - Form 4
June 30, 2026 Phillips Elizabeth DSVP, People & Culture Other change 4,995 $36.25 $181.1K Form 4
June 30, 2026 Phillips Elizabeth DSVP, People & Culture Shares withheld for tax 793 $36.25 $28.7K Form 4
June 30, 2026 Hull Thomas David IIIPresident & CEO, Director Exercised options 54,388 - - Form 4
June 30, 2026 Hull Thomas David IIIPresident & CEO, Director Other change 17,000 $36.25 $616.3K Form 4
June 30, 2026 Hull Thomas David IIIPresident & CEO, Director Shares withheld for tax 16,243 $36.25 $588.8K Form 4
June 30, 2026 Noble Ryan S.SVP, Sales & Marketing Dev Exercised options 7,206 - - Form 4
June 30, 2026 Noble Ryan S.SVP, Sales & Marketing Dev Other change 3,000 $36.25 $108.8K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns KEQU

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Zucker Anita G13D, may seek influence 6.8% 193,876 February 5, 2025
Minerva Advisors LLC13G, passive with 4 related filers 5.2% 149,410 June 29, 2026

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 32 managers reported a position.

HolderSharesValueChange on quarter
Northern Trust Corp238,111$8.5M-7,853
Dimensional Fund Advisors LP175,042$6.2M-2,297
Minerva Advisors LLC149,410$5.3M+12,705
Vanguard Capital Management LLC110,051$3.9M-2,462
Punch & Associates Investment Management, Inc.105,545$3.7M+4,843
Renaissance Technologies LLC95,311$3.4M-3,200
De Lisle Partners LLP52,626$1.9M0
Royce & Associates LP49,700$1.8M+1,700
American Century Companies Inc49,530$1.8M-21
Geode Capital Management, LLC24,931$885.8K+452
Mink Brook Asset Management LLC21,447$761.8K0
Northeast Investment Management20,000$710.4K0
Morgan Stanley16,828$597.7K-3,106
Vanguard Fiduciary Trust Co13,172$467.9K+88
Wealth Enhancement Advisory Services, LLC12,694$464.5K0
BlackRock, Inc.11,978$425.5K+2,054
Bridgeway Capital Management, LLC11,815$419.7K0
State Street Corp10,034$356.4K0
Verdad Advisers, LP10,000$355.2Knew
LPL Financial LLC8,000$284.2K0

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

9 insiders reported holding 180,691 shares in total, about $6.1M at the last price.

HolderSharesAs of
Hull Thomas David IIIPresident & CEO, Director 54,145 June 30, 2026
Pyle Margaret BDirector 36,89136,891 held indirectly March 26, 2026
Gehl Keith MDirector 22,409 May 1, 2026
Noble Ryan S.SVP, Sales & Marketing Dev 16,240 June 30, 2026
Ranade MandarSVP, IT & Engineering 16,215 June 30, 2026
Gardner Donald T. IIIChief Financial Officer 14,802 June 30, 2026
Phillips Elizabeth DSVP, People & Culture 9,116 June 30, 2026
Batdorff Douglas J.SVP, Manufacturing Operations 8,170 June 30, 2026
Campbell John JetteDirector 2,703 May 1, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about KEQU

What does Kewaunee Scientific Corp do?

Kewaunee Scientific Corp is a company in the Industrials sector, listed on NASDAQ as KEQU. Its shares trade on NASDAQ under the ticker KEQU.

What is Kewaunee Scientific Corp's net worth?

Kewaunee Scientific Corp has a market value (market cap) of $96.8M at the latest share price, and shareholders' equity of $75M on its balance sheet at July 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Kewaunee Scientific Corp profitable?

Yes. Over the twelve months to July 31, 2026 it reported net income of $8.2M on revenue of $277.2M, a net margin of 3.0%.

How much revenue does Kewaunee Scientific Corp make?

Over the twelve months to July 31, 2026 Kewaunee Scientific Corp reported revenue of $277.2M. That is 5.3% more than a year earlier.

When did Kewaunee Scientific Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on September 11, 2026. It covers the period to July 31, 2026.

When is Kewaunee Scientific Corp's next earnings report?

Kewaunee Scientific Corp's next report is expected around December 9, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare KEQU with

Compare KEQU with any company

Follow KEQU

Get an email when Kewaunee Scientific Corp files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when KEQU files with the SEC.

Where the numbers come from

Financial figures are the values Kewaunee Scientific Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.